Versant Capital Management
GSK icon

Versant Capital Management’s GSK GSK Stock Holding History

Versant Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$624K Sell
12,946
-609
-4% -$31.1K 0.05% 230
2026
Q2 		$711K Buy
13,555
+142
+1% +$7.51K 0.06% 193
2026
Q1 		$740K Buy
13,413
+2,071
+18% +$112K 0.07% 174
2025
Q4 		$556K Buy
11,342
+1,342
+13% +$62.6K 0.07% 199
2025
Q3 		$432K Sell
10,000
-589
-6% -$23K 0.06% 235
2025
Q2 		$407K Buy
10,589
+4,273
+68% +$163K 0.06% 227
2025
Q1 		$245K Buy
6,316
+6,228
+7,077% +$228K 0.04% 354
2024
Q4 		$2.98K Buy
88
+22
+33% +$792 ﹤0.01% 1959
2024
Q3 		$2.7K Buy
66
+42
+175% +$1.72K ﹤0.01% 1490
2024
Q2 		$924 Hold
24
– – ﹤0.01% 1690
2024
Q1 		$1.03K Sell
24
-676
-97% -$27.9K ﹤0.01% 1533
2023
Q4 		$25.9K Buy
700
+676
+2,817% +$24.3K 0.01% 403
2023
Q3 		$870 Hold
24
– – ﹤0.01% 1563
2023
Q2 		$855 Hold
24
– – ﹤0.01% 1658
2023
Q1 		$854 Hold
24
– – ﹤0.01% 1482
2022
Q4 		$843 Hold
24
– – ﹤0.01% 1335
2022
Q3 		$1K Hold
24
– – ﹤0.01% 1237
2022
Q2 		$1K Buy
+24
New +$1.32K ﹤0.01% 1259
2021
Q3 		– Sell
-220
Closed -$11K – 1515
2021
Q2 		$11K Buy
+220
New +$10.6K ﹤0.01% 683
2020
Q4 		– Sell
-247
Closed -$11K – 1416
2020
Q3 		$11K Hold
247
– – ﹤0.01% 624
2020
Q2 		$12K Hold
247
– – 0.01% 568
2020
Q1 		$11K Buy
+247
New +$13.2K 0.01% 525
2018
Q1 		– Sell
-137
Closed -$6K – 1550
2017
Q4 		$6K Buy
+137
New +$6.33K ﹤0.01% 1065

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Versant Capital Management's GSK Position: Q3 2026 in Review

Versant Capital Management reduced its GSK (GSK) stake by 4.5% in Q3 2026, selling an estimated $31.1K and leaving 12,946 shares worth $624K. The position accounts for 0.05% of the portfolio, ranked #230.

Versant Capital Management first reported a position in GSK in Q4 2017 and has held it in 23 quarters since. The position peaked at $740K in Q1 2026. 748 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Versant Capital Management held 12,946 shares of GSK worth $624K as of Q3 2026.
  • Versant Capital Management sold 609 GSK shares in Q3 2026, an estimated $31.1K.
  • GSK made up 0.05% of Versant Capital Management's portfolio in Q3 2026, its #230 holding.
  • Versant Capital Management first reported a position in GSK in Q4 2017 and has held it in 23 quarters since.
  • Versant Capital Management's GSK position peaked at $740K in Q1 2026.
  • 748 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.